HDB offers compound screening and profiling services to assist our clients for lead identification and optimization. We focus our efforts on lead selection and assessment to gear at providing clients with reliable and accurate information through scientific procedures. Panels of profiling assays including biochemical assays and cell-based functional assays (i.e. in various target classes such as GPCRs, enzymes, ion channels and transporters), in vitro ADMET assays and pathway-based cellular phenotypic assays as well as high-content assays offer an integrated tool for clients to better characterize and optimize the pharmacology and toxicity profiles of their lead compounds.